{"id":156190,"date":"2017-12-21T16:51:51","date_gmt":"2017-12-21T16:51:51","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=156190"},"modified":"2017-12-21T16:51:51","modified_gmt":"2017-12-21T16:51:51","slug":"vanzarea-ad-pharma-confirmata-negocierile-au-fost-foarte-intense-in-ultimele-5-luni","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=156190","title":{"rendered":"V\u00e2nzarea A&#038;D Pharma, confirmat\u0103: &#8220;Negocierile au fost foarte intense \u00een ultimele 5 luni&#8221;"},"content":{"rendered":"<p>\nReprezentan\u0163ii Penta Investments nu ofer\u0103 detalii referitoare la valoarea tranzac\u0163iei \u00eens\u0103, potrivit unor surse ale Business Magazin, aceasta ar fi cuprins\u0103 \u00eentre 100 \u015fi 200 de milioane de euro.<\/p>\n<p>\nTranzac\u0163ia a fost semnat\u0103 ieri sear\u0103 (20 decembrie), iar negocierile au fost foarte intense pe parcursul ultimelor cinci luni, a descris tranzac\u0163ia pentru Business Magazin Martin Danko, external relations manager \u00een cadrul Penta Investments.<\/p>\n<p>\n&#8220;Penta este un investitor pe termen lung. \u00cen sectorul farmaciilor, ne dezvolt\u0103m prezen\u0163a prin intermediul Dr. Max, un lan\u0163 cu 1.300 de farmacii \u00een Europa Central\u0103 \u015fi de Est. Strategia noastr\u0103 const\u0103 \u00een a ne pozi\u0163iona ca lider de pia\u0163\u0103 pentru a dezvolta produse de calitate \u015fi accesibile pentru pacien\u0163ii no\u015ftri. Achizi\u0163ia A&#038;D Pharma este o realizare \u00een atingerea acestui obiectiv&#8221;, spune Danko.<\/p>\n<p>\nCehii au mai negociat anterior preluarea A&#038;D Pharma acum mai bine de cinci ani, \u00eens\u0103 atunci deal-ul a picat, potrivit informa\u0163iilor ZF primite \u00een momentul \u00een care tranzac\u0163ia a intrat \u00een linie dreapt\u0103. Tot atunci, ZF scria c\u0103 valoarea tranzac\u0163iei o plaseaz\u0103 \u00een topul celor mai mari din acest an \u015fi c\u0103 plata se va face \u00een etape, mai exact se va achita o sum\u0103 ini\u0163ial pentru ca apoi, \u00een func\u0163ie de rezultatele din urm\u0103torii ani, s\u0103 fie pl\u0103tite noi tran\u015fe. Grupul A&#038;D Pharma este controlat de Walid Abboud, Roger Akoury, Ludovic Robert \u015fi Michel Eid, fiind liderul pie\u0163ei de distribu\u0163ie de medicamente prin compania Mediplus Exim \u015fi cel de-al doilea juc\u0103tor din pia\u0163a de retail de profil cu re\u0163elele Sensiblu \u015fi Punkt. \u00cempreun\u0103 cele dou\u0103 au afaceri de 5,7 mld. lei (1,3 mld. euro) \u015fi un profit brut cumulat de 152 mil. lei, scrie ZF.<\/p>\n<p>\nFondul ceh de investi\u0163ii Penta Investments, prin intermediul grupului farma Dr. Max, a intrat pe pia\u0163a local\u0103 \u00een vara acestui an, c\u00e2nd a preluat lan\u0163ul de 31 de farmacii deschise sub brandul Farmaciile Arta, precum \u015fi o companie de distribu\u0163ie de medicamente. Fondul de investi\u0163ii Penta Investments este activ pe zece pie\u0163e din Europa \u015fi are sub administrare active de 8,5 mld. euro, iar pe pia\u0163a local\u0103 acesta era prezent din 2015 pe pia\u0163a pariurilor sportive \u015fi a jocurilor de noroc, de\u0163in\u00e2nd compania Fortuna Entertainment, potrivit ZF.<\/p>\n<p>\n&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tranzac\u0163ia dintre A&#038;D Pharma, liderul pie\u0163ei de distribu\u0163ie de medicamente (prin compania Mediplus Exim) \u015fi cel de-al doilea juc\u0103tor din pia\u0163a de retail de profil (cu re\u0163elele Sensiblu \u015fi Punkt) \u015fi fondul ceh de investi\u0163ii Penta Investments a fost confirmat\u0103 de un comunicat de pres\u0103 trimis de reprezentan\u0163ii companiilor. <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[8813,272,470,32653,8088,8789,7903,30016,149,516,60,400],"class_list":["post-156190","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-ad-pharma","tag-companie","tag-cumparare","tag-distribuire","tag-farma","tag-fond","tag-fond-de-investitii","tag-gigant","tag-investitii","tag-lider","tag-piata","tag-tranzactie"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/156190","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=156190"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/156190\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=156190"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=156190"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=156190"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}